ATE466857T1 - Neue piperidin-antibiotika - Google Patents

Neue piperidin-antibiotika

Info

Publication number
ATE466857T1
ATE466857T1 AT05786765T AT05786765T ATE466857T1 AT E466857 T1 ATE466857 T1 AT E466857T1 AT 05786765 T AT05786765 T AT 05786765T AT 05786765 T AT05786765 T AT 05786765T AT E466857 T1 ATE466857 T1 AT E466857T1
Authority
AT
Austria
Prior art keywords
antibiotics
new piperidine
piperidine
new
piperidine antibiotics
Prior art date
Application number
AT05786765T
Other languages
English (en)
Inventor
Jean-Philippe Surivet
Christian Hubschwerlen
Acklin Cornelia Zumbrunn
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35453391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE466857(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE466857T1 publication Critical patent/ATE466857T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT05786765T 2004-10-05 2005-10-03 Neue piperidin-antibiotika ATE466857T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2004011087 2004-10-05
PCT/IB2005/053238 WO2006038172A1 (en) 2004-10-05 2005-10-03 New piperidine antibiotics

Publications (1)

Publication Number Publication Date
ATE466857T1 true ATE466857T1 (de) 2010-05-15

Family

ID=35453391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05786765T ATE466857T1 (de) 2004-10-05 2005-10-03 Neue piperidin-antibiotika

Country Status (10)

Country Link
US (1) US20070173532A1 (de)
JP (1) JP2008515796A (de)
CN (1) CN101039935B (de)
AR (1) AR051051A1 (de)
AT (1) ATE466857T1 (de)
CA (1) CA2581057A1 (de)
DE (1) DE602005021133D1 (de)
ES (1) ES2343127T3 (de)
TW (1) TW200616959A (de)
WO (1) WO2006038172A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE441645T1 (de) * 2005-05-25 2009-09-15 Actelion Pharmaceuticals Ltd Neue antibiotische derivate
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP1943222A1 (de) * 2005-10-13 2008-07-16 Morphochem Aktiengesellschaft Für Kombinatorische Chemie 5-chinolinderivate mit antibakterieller aktivität
EP2001887B1 (de) 2006-04-06 2010-09-15 Glaxo Group Limited Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (de) 2007-05-18 2008-11-19 Glaxo Group Limited Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
TW200819457A (en) * 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
EP2352734A1 (de) 2008-10-17 2011-08-10 Glaxo Group Limited Als antibakterielle mittel verwendete tricyclische stickstoffverbindungen
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
EP2566863B1 (de) * 2010-05-06 2014-05-14 Council of Scientific and Industrial Research Chinolylpiperazin-substituierte thiolactonverbindungen und herstellungsverfahren dafür
US10702521B2 (en) 2014-08-22 2020-07-07 Glaxosmithkline Intellectual Property Development Limited Methods for treating neisseria gonorrhoeae infection with substituted 1,2-dihydro-2A,5,8A-triazaacenaphthylene-3,8-diones
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
LT3483164T (lt) 2017-03-20 2020-05-11 Forma Therapeutics, Inc. Pirolpirolo kompozicijos kaip piruvato kinazės (pkr) aktyvatoriai
EP3852791B1 (de) 2018-09-19 2024-07-03 Novo Nordisk Health Care AG Aktivierung von pyruvatkinase r
EP3853206B1 (de) 2018-09-19 2024-04-10 Novo Nordisk Health Care AG Behandlung von sichelzellanämie mit einer pyruvatkinase-r-aktivierenden verbindung
HRP20251148T1 (hr) 2019-09-19 2025-11-21 Novo Nordisk Health Care Ag Pripravci koji aktiviraju piruvat-kinazu r (pkr)
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R
CN118684669B (zh) * 2024-07-05 2025-11-25 大连理工大学 一种新型手性联吡啶的制备方法及其在催化反应的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
JP2002535323A (ja) * 1999-01-20 2002-10-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー プロテインキナーゼ阻害剤としてのピペリジニルキノリン
FR2798656B1 (fr) * 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
TW200406413A (en) * 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
DE10247233A1 (de) * 2002-10-10 2004-06-17 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
EP1551829B1 (de) * 2002-10-10 2010-04-07 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
US6982334B2 (en) * 2002-12-20 2006-01-03 Aventis Pharma S.A. Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität

Also Published As

Publication number Publication date
ES2343127T3 (es) 2010-07-23
TW200616959A (en) 2006-06-01
JP2008515796A (ja) 2008-05-15
CN101039935B (zh) 2011-04-20
DE602005021133D1 (de) 2010-06-17
US20070173532A1 (en) 2007-07-26
CN101039935A (zh) 2007-09-19
CA2581057A1 (en) 2006-04-13
AR051051A1 (es) 2006-12-13
WO2006038172A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
ATE414693T1 (de) Neuartige cis-imidazoline
EP1730337A4 (de) Anorganische nanodrähte
EP1788047A4 (de) Wasserabweisende/ölabweisende zusammensetzung
ATE466857T1 (de) Neue piperidin-antibiotika
FIU20100190U0 (fi) Taajuusmuuttajan konfigurointi
ATE387440T1 (de) Neue 4-benzylidenpiperidinderivate
DE602006016573D1 (de) Substituierte piperidine
DE602005023145D1 (de) Neue androgene
SE0400898L (sv) Flytkonstruktion
ATE425167T1 (de) Neue pyridothienopyrimidinderivate
DE602005017191D1 (de) Geruchsreduzierte waschstück-zusammensetzung
FR2871686B1 (fr) Composition anti-decoloration
AT500198B8 (de) Ladewagen
EP1708704A4 (de) 4-arylpiperidine
AT500249A3 (de) Scheibenegge
AT501079B8 (de) Türe
DE602005016400D1 (de) Stellgliedanordnung
AT7802U3 (de) Parfum-zerstäuber
FI6354U1 (fi) Ohjauslaite
SE0400205D0 (sv) Composition
ITRO20040014A1 (it) Pannello legnocuoio
UA11052S (uk) Двері
UA11217S (uk) Двері
UA11208S (uk) Двері
UA11209S (uk) Двері

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties